Skip to main content
ENGN logo

ENGN

enGene Therapeutics Inc.
$1.78 +0.02 (+1.14%) At close · Jul 2
Market Cap
$119.24M
Shares
66,989,466

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 59
Total Value: $380,009,072
Total Shares: 55,801,630

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 59 13F filers · Δ vs Dec 31, 2025
Top Holder
17.3%
Dec 2023 → Mar 2026 · range 16.4% – 61.2%
+0.9 pts
Top 5
53.6%
Dec 2023 → Mar 2026 · range 48.8% – 98.5%
+4.8 pts
Top 10
77.2%
Dec 2023 → Mar 2026 · range 72.4% – 100.0%
+4.8 pts
HHI
788
Dec 2023 → Mar 2026 · range 702 – 4,156
Broadly held+86

Quarterly Activity

vs Dec 31, 2025
New
12
Increased
22
Decreased
14
Sold Out
10
Unchanged
11
Holder count: +2
Institutional value: -30.1%
Shares held: -7.3%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 59 of 59
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1980845 CUSIP 29286M105 Visit website